A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis. [electronic resource]
Producer: 20060629Description: 264-72 p. digitalISSN:- 0009-9104
- Animals
- Antitubercular Agents -- therapeutic use
- Colony Count, Microbial
- Cyclooxygenase Inhibitors -- administration & dosage
- Cytokines -- immunology
- Disease Models, Animal
- Hypersensitivity, Delayed -- immunology
- Immunotherapy -- methods
- Lung -- immunology
- Male
- Mice
- Mice, Inbred BALB C
- Niflumic Acid -- administration & dosage
- Nitric Oxide Synthase Type II -- immunology
- Prostaglandin Antagonists -- administration & dosage
- Proteoglycans -- administration & dosage
- Receptors, Transforming Growth Factor beta -- administration & dosage
- Th1 Cells -- immunology
- Th2 Cells -- immunology
- Transforming Growth Factor beta -- antagonists & inhibitors
- Tuberculosis, Pulmonary -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.